- United States
- /
- Chemicals
- /
- NYSE:ECL
Why Ecolab (ECL) Is Drawing Fresh Attention
Ecolab (ECL) is back in focus after reporting solid second quarter 2026 results that relied on Global High Tech demand and expanding digital platforms to offset energy related cost swings.
Recent trading has been softer, with the 30-day share price return down 4.58% and the 7-day return down 2.64%. Even so, Ecolab still shows a 3.41% share price gain year to date and a 57.72% three-year total shareholder return that points to momentum built over a longer stretch.
See how Ecolab compares with peers facing similar cost swings and digital tailwinds by reviewing our curated list of 11 resilient stocks with low risk scores.
After a soft stretch for the share price, Ecolab now trades at a sizeable discount to analyst targets while sitting slightly above one estimate of intrinsic value. Is the market being cautious for good reason, or is it mispricing the story?
Most Popular Narrative: 16.1% Undervalued
Ecolab closed at $271.60 compared with a narrative fair value of about $323.71, which puts the spotlight on how growth, margins, and cash flows intersect.
Ecolab is focusing on expanding its One Ecolab growth initiative, aiming to capitalize on market share gains and increased value pricing. This initiative is expected to drive revenue growth and improve net margins by delivering exceptional value to customers.
Curious what powers that $323.71 figure? The narrative leans on steady top line expansion, firmer profitability, and a richer earnings multiple. Want the full blueprint?
The most followed thesis for Ecolab builds in sustained revenue growth, higher profit margins over time, and a future valuation multiple that remains above the wider US chemicals sector, all filtered through a 7.45% discount rate that brings those projected cash flows back to today.
Result: Fair Value of $323.71 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, softer demand in heavy industrial markets and rising tariff related costs could squeeze Ecolab if its pricing power or the acceptance of surcharges starts to fade.
Find out about the key risks to this Ecolab narrative.
Another View: Ecolab Through the P/E Lens
The narrative model points to Ecolab being 16.1% undervalued, yet the current P/E of 36x tells a very different story. That figure sits well above the US Chemicals industry at 24.2x, the peer average at 19.4x, and even the 24.7x fair ratio the market could move toward. If sentiment cools, how comfortable are you with that valuation gap?
For a clearer feel of what the current multiple implies, and how it compares with broader peers, take a look at our valuation breakdown via the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals on Ecolab’s valuation and risk reward balance can tempt you to react fast, so move quickly, but base your decision on the underlying numbers and the full set of 1 key reward and 2 important warning signs
Looking for more investment ideas beyond Ecolab?
If Ecolab has your attention, do not stop here. Broaden your watchlist and pressure test your thesis against other opportunities before the market moves first.
- Target resilient balance sheets and steady fundamentals by scanning our curated list of solid balance sheet and fundamentals (23 results) that can help anchor a portfolio when conditions shift.
- Chase potential mispricing opportunities by reviewing the 18 high quality undiscovered gems that many investors may not be watching yet.
- Strengthen your income angle by assessing companies in the 6 dividend fortresses that focus on robust cash flows and meaningful payouts.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Ecolab might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Oracle has $638 billion of orders it can't fill yet. Tonight tells us how much it's costing to get ready.

Sixty-eight percent gross margin business is buying its way into a thirty-five percent gross margin business, and revenue growth is the metric everyone is watching.
This is important about Oracle. Nvidia went to six of the biggest asset managers on earth to make sure someone else held this risk. Oracle just borrowed the money and held it itself.
Andrew LeggetAre social media stocks the new Big Tobacco?

About NYSE:ECL
Ecolab
Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
Average dividend payer with mediocre balance sheet.